WHO ICTRP trial

Prospective multicenter trial on the identification of novel biomarkers for…

JPRN-UMIN000009622 · Japan Primary Registries Network (JPRN) · Not Recruiting

Key facts

Trial ID JPRN-UMIN000009622
Public title Prospective multicenter trial on the identification of novel biomarkers for Sunitinib therapy in the treatment of Japanese patients with metastatic renal cell carcinoma
Scientific title Prospective multicenter trial on the identification of novel biomarkers for Sunitinib therapy in the treatment of Japanese patients with metastatic renal cell carcinoma - Prospective multicenter trial on the identification of novel biomarkers for Sunitinib therapy in the treatment of metastatic…
Primary sponsor Tokyo metropolitan Sutent study group
Registry Japan Primary Registries Network (JPRN)
Recruitment status Not Recruiting
Study type Observational
Phase Not selected
Countries Japan
Conditions renal cell carcinoma
Registration date Dec 25, 2012
Target size 70
Registry page center6.umin.ac.jp

At a glance

  • No Results available

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About WHO ICTRP trial registrations

The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.

Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date:

Browse all WHO ICTRP trial registrations